Learn More
Medchemexpress LLC LGD-6972 | 1207989-09-0 | MFCD28411370 | 98.0% | 702.90 g/mol | C43H46N2O5S | 25MG

Supplier: Medchemexpress LLC HY1252525MG
LGD-6972 is an orally active, selective glucagon receptor (GCGR) antagonist used for research into glucose regulation and type 2 diabetes. It inhibits GCGR signaling to reduce glucagon-stimulated cAMP and hepatic glucose production; reported molecular formula C43H46N2O5S, molecular weight 702.9 g/mol, CAS 1207989-09-0, and typical supplied purity is 98.0%.
- Selective oral GCGR antagonist for glucose regulation research.
- Reduces glucagon-stimulated cAMP and hepatic glucose production.
- Demonstrated glucose-lowering activity in preclinical and clinical studies.
- Available in multiple salt forms and small-scale pack sizes for laboratory use.
- High purity suitable for analytical and biological assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.